#neurocrine

[moneyhealthfinance-blog]

Mid-Day Market Update: NASDAQ Rises 2%; Neurocrine Biosciences Shares Plunge

Mid-Day Market Update: NASDAQ Rises 2%; Neurocrine Biosciences Shares Plunge

Midway through trading Wednesday, the Dow traded up 1.45 percent to 24,722.86 while the NASDAQ climbed 2.01 percent to 7,173.22. The S&P also rose, gaining 1.55 percent to 2,677.63.

Leading and Lagging Sectors

On Wednesday, the information technology shares climbed 1.8 percent. Meanwhile, top gainers in the sector included Aurora Mobile Ltd – ADR (NASDAQ: JG) up 15 percent, and Himax…

View On WordPress

[coco-manus-blog]

FDA needs more time to review AbbVie, Neurocrine - https://goo.gl/o4mbLP - #AbbVie, #FDA, #Neurocrine, #Nutrition, #Review, #Time